Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Scienture Holdings, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +1 vs. Q3 2025
- Shares held
- 1.36M
- +910.3K (+202.5%) vs. Q3 2025
- Total value
- $693.6K
- +$311.9K (+81.7%) vs. Q3 2025
- New holders
- 1
- 9 more added
- Sold out
- 0
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $709.1K |
| Q1 2026 | 13 | $405.1K |
| Q4 2025 | 12 | $693.6K |
| Q3 2025 | 11 | $381.8K |
| Q2 2025 | 8 | $111.9K |
| Q1 2025 | 9 | $160.1K |
| Q4 2024 | 9 | $566.7K |
| Q3 2024 | 7 | $301.5K |
| Q2 2024 | 6 | $395.7K |
| Q1 2024 | 9 | $805.3K |
| Q4 2023 | 6 | $14.5K |
| Q3 2023 | 6 | $14.2K |
| Q2 2023 | 8 | $298.2K |
| Q1 2023 | 12 | $69.2K |
| Q4 2022 | 15 | $376.0K |
| Q3 2022 | 13 | $658.0K |
| Q2 2022 | 13 | $953.0K |
| Q1 2022 | 13 | $1.49M |
| Q4 2021 | 15 | $1.52M |
| Q3 2021 | 11 | $2.60M |
| Q2 2021 | 12 | $2.25M |
| Q1 2021 | 15 | $5.83M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Scienture Holdings, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 606,151 | $309.1K | 0.00% | +449,133+286.0% | Added |
| Geode Capital Management, LLC | 316,201 | $161.3K | 0.00% | +229,398+264.3% | Added |
| UBS Group AG | 220,941 | $112.7K | 0.00% | +106,590+93.2% | Added |
| Virtu Financial LLC | 89,930 | $46.0K | 0.00% | +89,930 | New |
| Two Sigma Securities, LLC | 50,891 | $26.0K | 0.00% | +33,091+185.9% | Added |
| Commonwealth Equity Services, LLC | 44,798 | $22.9K | 0.00% | +1,000+2.3% | Added |
| Private Advisor Group, LLC | 15,002 | $7.65K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 13,894 | $7.09K | 0.00% | +1,147+9.0% | Added |
| Tower Research Capital LLC (TRC) | 1,625 | $829 | 0.00% | +266+19.6% | Added |
| Bank of America Corp | 287 | $146 | 0.00% | +183+176.0% | Added |
| Citigroup Inc | 37 | $19 | 0.00% | −466−92.6% | Reduced |
| SBI Securities Co., Ltd. | 10 | $5 | 0.00% | +6+150.0% | Added |